Market Cap 46.83M
Revenue (ttm) 37.87M
Net Income (ttm) -6.48M
EPS (ttm) N/A
PE Ratio 27.18
Forward PE N/A
Profit Margin -17.11%
Debt to Equity Ratio 0.19
Volume 15,095
Avg Vol 94,630
Day's Range N/A - N/A
Shares Out 14.96M
Stochastic %K 34%
Beta -0.39
Analysts Strong Buy
Price Target $8.50

Company Profile

Cumberland Pharmaceuticals Inc., a specialty pharmaceutical company, focuses on the acquisition, development, and commercialization of prescription products for hospital acute care, gastroenterology, and oncology in the United States and internationally. The company offers Acetadote, an injection for the treatment of acetaminophen poisoning; Caldolor, an injection for the treatment of pain and fever; Kristalose, a prescription laxative oral solution for the treatment of constipation; Sancuso, an...

Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Phone: 615 255 0068
Fax: 615 255 0094
Address:
1600 West End Avenue, Suite 1300, Nashville, United States
BioResearcher
BioResearcher Aug. 15 at 6:12 PM
$CPIX Management is lucky to have these 2 renown docs to serve as Principle Investigators (PI). These 2 are heart doctors that specialized in DMD Cardiomyopathy. These doctors should give FDA a lot of confidence in this trial data:
0 · Reply
BioResearcher
BioResearcher Aug. 15 at 5:39 PM
$CPIX Dr. Jonathan Soslow is a renown doctor in the field of DMD Cardiomyopathy. FDA granted funding to Dr. Soslow to lead a group of scientists to conduct a Natural Historical Data Study for DMD Cardiomyopathy, which CAPR's Linda used in their BLA data. CPIX is fortunate to have Dr. Soslow as their co-PI in their trial, and he also responsible for MRI imaging for CPIX' trial. Here is what Dr. Soslow said about the result of CPIX' trial:
1 · Reply
BioResearcher
BioResearcher Aug. 15 at 5:21 PM
$CPIX The reason I think there should be 41 patients stay in the OLE Trial until the end is: The drug is oral pill taken at home just like daily vitamin, no side effect, there is no need to go to clinic. The patients only need to come in once a year to have MRI and safety check, and drug refill. Since the pills can bring benefit and harmless like multi-vitamin pill, then why not just stay in the OLE Trial.
0 · Reply
YoloAlfred
YoloAlfred Aug. 15 at 4:15 PM
$CPIX All i have to do is wait now
0 · Reply
YoloAlfred
YoloAlfred Aug. 15 at 3:53 PM
$CPIX 6.3 VALUE, MOMENTUM, QUALITY ....Overal Rating: STRONG WeBull
0 · Reply
YoloAlfred
YoloAlfred Aug. 15 at 3:51 PM
$CPIX CFRA RATING 08/08/2025 STRONG BUY...ACROSS EVERYTHING
0 · Reply
YoloAlfred
YoloAlfred Aug. 15 at 3:27 PM
$CPIX added more now 5,444 shares
0 · Reply
WesleyVanguard3
WesleyVanguard3 Aug. 15 at 2:16 PM
$CPIX Just added more shares Hoping for the fast track
0 · Reply
YoloAlfred
YoloAlfred Aug. 15 at 1:39 PM
$CPIX add them up.....100% shares held
0 · Reply
BioResearcher
BioResearcher Aug. 15 at 12:25 PM
$CAPR $CPIX Also, Recurrent Respiratory Papillomatosis (RRP) is a benign disease, it does not cause death. and it can be surgically removed. While DMD Heart disease is the leading cause of death. It is very fatal. and there has been no approved drug for it.
1 · Reply
Latest News on CPIX
VIBATIV® RECEIVES MARKETING APPROVAL IN CHINA

Feb 18, 2025, 7:30 AM EST - 6 months ago

VIBATIV® RECEIVES MARKETING APPROVAL IN CHINA


FDA APPROVES ACETADOTE® sNDA

Dec 9, 2024, 4:05 PM EST - 8 months ago

FDA APPROVES ACETADOTE® sNDA


New Study Compares Caldolor® (ibuprofen injection) to ketorolac

Nov 5, 2024, 4:05 PM EST - 10 months ago

New Study Compares Caldolor® (ibuprofen injection) to ketorolac


BioResearcher
BioResearcher Aug. 15 at 6:12 PM
$CPIX Management is lucky to have these 2 renown docs to serve as Principle Investigators (PI). These 2 are heart doctors that specialized in DMD Cardiomyopathy. These doctors should give FDA a lot of confidence in this trial data:
0 · Reply
BioResearcher
BioResearcher Aug. 15 at 5:39 PM
$CPIX Dr. Jonathan Soslow is a renown doctor in the field of DMD Cardiomyopathy. FDA granted funding to Dr. Soslow to lead a group of scientists to conduct a Natural Historical Data Study for DMD Cardiomyopathy, which CAPR's Linda used in their BLA data. CPIX is fortunate to have Dr. Soslow as their co-PI in their trial, and he also responsible for MRI imaging for CPIX' trial. Here is what Dr. Soslow said about the result of CPIX' trial:
1 · Reply
BioResearcher
BioResearcher Aug. 15 at 5:21 PM
$CPIX The reason I think there should be 41 patients stay in the OLE Trial until the end is: The drug is oral pill taken at home just like daily vitamin, no side effect, there is no need to go to clinic. The patients only need to come in once a year to have MRI and safety check, and drug refill. Since the pills can bring benefit and harmless like multi-vitamin pill, then why not just stay in the OLE Trial.
0 · Reply
YoloAlfred
YoloAlfred Aug. 15 at 4:15 PM
$CPIX All i have to do is wait now
0 · Reply
YoloAlfred
YoloAlfred Aug. 15 at 3:53 PM
$CPIX 6.3 VALUE, MOMENTUM, QUALITY ....Overal Rating: STRONG WeBull
0 · Reply
YoloAlfred
YoloAlfred Aug. 15 at 3:51 PM
$CPIX CFRA RATING 08/08/2025 STRONG BUY...ACROSS EVERYTHING
0 · Reply
YoloAlfred
YoloAlfred Aug. 15 at 3:27 PM
$CPIX added more now 5,444 shares
0 · Reply
WesleyVanguard3
WesleyVanguard3 Aug. 15 at 2:16 PM
$CPIX Just added more shares Hoping for the fast track
0 · Reply
YoloAlfred
YoloAlfred Aug. 15 at 1:39 PM
$CPIX add them up.....100% shares held
0 · Reply
BioResearcher
BioResearcher Aug. 15 at 12:25 PM
$CAPR $CPIX Also, Recurrent Respiratory Papillomatosis (RRP) is a benign disease, it does not cause death. and it can be surgically removed. While DMD Heart disease is the leading cause of death. It is very fatal. and there has been no approved drug for it.
1 · Reply
BioResearcher
BioResearcher Aug. 15 at 12:17 PM
$CPIX $CAPR Great news for rare diseases drugs: Precigen 's drug has received FULL approval, not Accelerated Approval, with only 35 patients phase 2 trial! No Phase 3 confirmation trial is needed. This is awesome! Precigen just asked for Accelerated Approval, but this FDA has granted them FULL approval! just based on 35 patients Trial. The message is clear: this new FDA wants drugs for rare diseases to hit the market as soon as they see first-sight of efficacy and safety. They even said it in the approval letter. It seems like this new FDA has learned a lesson from the recent Prasad's incident. :-)
2 · Reply
YoloAlfred
YoloAlfred Aug. 15 at 11:59 AM
$CPIX I dont get mad when i see this stock drop 10% -30% with a tiny amount of volume....it gets me excited....knowing when the good news hits....its melt your face time
0 · Reply
YoloAlfred
YoloAlfred Aug. 15 at 11:55 AM
$CPIX All my statements are my personal opinion....not fact
0 · Reply
BioResearcher
BioResearcher Aug. 15 at 11:54 AM
$CPIX Also, Recurrent Respiratory Papillomatosis (RRP) is a benign disease, it does not cause death. and it can be surgically removed. While DMD Heart disease is the leading cause of death. It is very fatal. and there has been no approved drug for it. Now, I know why Management has cut short the OLE trial, and submit data to FDA so quickly. RRP's drug has accelerated approval yesterday and the approval letter from FDA shows that this new FDA wants to show that they are very flexible when it comes to rare disease (after the Dr. Prasad' recent incident).
0 · Reply
YoloAlfred
YoloAlfred Aug. 15 at 11:53 AM
$CPIX add 37.69%+41.52%+20.79%= 100% held shares......Market Maker will have no choice but to explode the ask.....with big news....$100 is possible......$10 is a guarantee with Accelerated Approval....🛑🚨Im not a financial adviser....always research for yourself...and know the risks that you could lose 100% of your money with any stock.
0 · Reply
YoloAlfred
YoloAlfred Aug. 15 at 11:41 AM
$CPIX A very small group of us already positioned will hit Really big before years end....Institutions will send this past $20 instantly before retail can say wtf is this in the trending list.....FDA showed this morning its willing to skip Accelerated Approval....and straight approve....RARE...indication...example (PGEN)
0 · Reply
YoloAlfred
YoloAlfred Aug. 15 at 11:18 AM
$CPIX when it comes to RARE ....this FDA is ready to Approve quickly
0 · Reply
YoloAlfred
YoloAlfred Aug. 15 at 11:17 AM
$CPIX an example of what FDA could also do for Ifetroban. This news break is from this morning
0 · Reply
YoloAlfred
YoloAlfred Aug. 15 at 12:04 AM
$CPIX hear
0 · Reply
YoloAlfred
YoloAlfred Aug. 14 at 9:19 PM
$CPIX would you agree 4-10 weeks to here from FDA?
1 · Reply
BioResearcher
BioResearcher Aug. 14 at 7:25 PM
0 · Reply
YoloAlfred
YoloAlfred Aug. 14 at 1:56 PM
$CPIX My average now is $3.29
0 · Reply